Nerlynx Tablet
Product Images NDC 70437-240

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Nerlynx (NDC 70437-240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Puma Biotechnology, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Ner00 0019 01)

Chemical structure of neratinib, the active ingredient in Nerlynx 40 mg tablets by Puma Biotechnology, Inc. The diagram shows the molecular skeleton with labeled functional groups and atoms representing the compound's chemical makeup.*

FDA Label Image

Figure 1 (Ner00 0019 02)

A Kaplan-Meier survival curve showing invasive disease-free survival (%) over 24 months after randomization comparing Neratinib and placebo groups. The graph includes hazard ratio and p-value statistics. The x-axis represents months after randomization, the y-axis shows survival percentage, and a table below indicates the number of subjects at risk for each group over time.*

FDA Label Image

Figure (Ner00 0019 03)

A Kaplan-Meier survival curve chart showing progression-free survival (%) over 36 months after randomization. Two groups are indicated: N+C (solid line) and L+C (dashed line). The chart includes survival rates with 95% confidence intervals at specified time points and a table of patients at risk below the x-axis.*

FDA Label Image

Figure (Ner00 0019 04)

A survival curve chart showing overall survival percentage over months after randomization for two treatment groups labeled N+C and L+C. The X-axis represents months from 0 to 57, and the Y-axis shows overall survival percentage from 10% to 100%. The chart includes a table below the X-axis indicating the number of patients at risk at various time points for each group.*

FDA Label Image

Principal Display Panel (Nerlynx 180 Tablets Carton Label)

Nerlynx (neratinib) 40 mg tablet carton label displaying the product name, strength, dosage form as tablets, and quantity of 180 tablets. The label includes storage instructions, manufacturer Puma Biotechnology, Inc., contact information, barcode, and that it is Rx only. The design features blue and gray text on a white background.*

FDA Label Image

Principal Display Panel (Nerlynx 180 Tablets Bottle Label)

Nerlynx (neratinib) tablets 40 mg packaging label for oral use. The label indicates 180 tablets in the package, manufactured for Puma Biotechnology, Inc., Los Angeles, CA. It includes storage instructions, a barcode, and specifies "Rx only." The label states each film-coated tablet contains 40 mg neratinib equivalent to 48.31 mg neratinib maleate.*

FDA Label Image

Principal Display Panel (Nerlynx 126 Tablets Carton Label)

Packaging label for Nerlynx (neratinib) tablets, 40 mg strength. The label shows 126 tablets in the package. Manufactured by Puma Biotechnology, Inc. The label includes dosage form as oral tablets, storage instructions, and the product NDC 70437-240-26. The label is predominantly white with blue and orange accents and includes a barcode and contact information for additional details.*

FDA Label Image

Principal Display Panel (Nerlynx 126 Tablets Bottle Label)

Nerlynx (neratinib) tablets 40 mg oral dosage form label showing packaging information. The label states 126 tablets per container, manufactured for Puma Biotechnology, Inc., Los Angeles, CA. It includes storage instructions, usual dosage reference, and a barcode with NDC 70437-240.*

FDA Label Image

Principal Display Panel (Nerlynx 133 Tablets Carton Label)

Packaging label for Nerlynx 40 mg tablets, containing 133 tablets. The label shows the proprietary name Nerlynx and the generic name neratinib, indicating it is an oral tablet. The labeler is Puma Biotechnology, Inc. The label includes storage instructions, dosage form, manufacturer information, and a barcode.*

FDA Label Image

Principal Display Panel (Nerlynx 133 Tablets Bottle Label)

Nerlynx (neratinib) tablets 40 mg oral dosage form label. The label indicates it contains 133 tablets, is prescription only, and is manufactured for Puma Biotechnology, Inc. Storage instructions specify keeping at controlled room temperature. The label includes a barcode and a warning to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.